The effect of CFTR modulator therapy on specific fungal and other rarer microbes is still unknown, and this is also true regarding the long-term impact of these therapies on specific virus-associated respiratory disease, although the initial signals are largely positive. This evidence concerns the gene CFTR and respiratory system disorder.